HEADER OXYGEN TRANSPORT 03-DEC-22 8FDL TITLE HUMAN HEMOGLOBIN WITH NITROSOCHLORAMPHENICOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOGLOBIN SUBUNIT ALPHA; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: SHR_HID2; COMPND 5 SYNONYM: ALPHA-GLOBIN,HEMOGLOBIN ALPHA CHAIN; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HEMOGLOBIN SUBUNIT BETA; COMPND 8 CHAIN: B, D; COMPND 9 SYNONYM: BETA-GLOBIN,HEMOGLOBIN BETA CHAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606 KEYWDS HEMOGLOBIN, CHLORAMPHENICOL, SULFINIC, OXYGEN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR S.M.POWELL,G.B.RICHTER-ADDO,L.M.THOMAS REVDAT 3 01-MAY-24 8FDL 1 JRNL REVDAT 2 25-OCT-23 8FDL 1 REMARK REVDAT 1 12-JUL-23 8FDL 0 JRNL AUTH S.M.POWELL,B.WANG,V.E.HERRERA,K.Y.PRATHER,N.T.NGUYEN, JRNL AUTH 2 E.G.ABUCAYON,L.M.THOMAS,M.K.SAFO,G.B.RICHTER-ADDO JRNL TITL CRYSTAL STRUCTURAL INVESTIGATIONS OF HEME PROTEIN JRNL TITL 2 DERIVATIVES RESULTING FROM REACTIONS OF ARYL- AND JRNL TITL 3 ALKYLHYDROXYLAMINES WITH HUMAN HEMOGLOBIN. JRNL REF J.INORG.BIOCHEM. V. 246 12304 2023 JRNL REFN ISSN 0162-0134 JRNL PMID 37406385 JRNL DOI 10.1016/J.JINORGBIO.2023.112304 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 3 NUMBER OF REFLECTIONS : 48475 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 2458 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.4100 - 4.6000 0.92 2684 147 0.1717 0.2019 REMARK 3 2 4.5900 - 3.6500 0.95 2705 138 0.1271 0.1791 REMARK 3 3 3.6500 - 3.1900 0.96 2720 147 0.1475 0.2205 REMARK 3 4 3.1900 - 2.9000 0.96 2746 141 0.1559 0.2101 REMARK 3 5 2.8900 - 2.6900 0.96 2747 148 0.1556 0.2073 REMARK 3 6 2.6900 - 2.5300 0.97 2712 156 0.1421 0.1954 REMARK 3 7 2.5300 - 2.4000 0.97 2763 143 0.1360 0.1873 REMARK 3 8 2.4000 - 2.3000 0.97 2735 151 0.1337 0.1949 REMARK 3 9 2.3000 - 2.2100 0.97 2748 147 0.1310 0.1935 REMARK 3 10 2.2100 - 2.1300 0.96 2731 146 0.1490 0.2081 REMARK 3 11 2.1300 - 2.0700 0.96 2712 132 0.1528 0.2082 REMARK 3 12 2.0700 - 2.0100 0.95 2703 135 0.1516 0.2173 REMARK 3 13 2.0100 - 1.9500 0.94 2629 145 0.1520 0.2675 REMARK 3 14 1.9500 - 1.9100 0.93 2654 148 0.1632 0.2445 REMARK 3 15 1.9100 - 1.8600 0.85 2378 134 0.1724 0.2435 REMARK 3 16 1.8600 - 1.8200 0.79 2213 125 0.1822 0.2188 REMARK 3 17 1.8200 - 1.7900 0.72 2019 93 0.2162 0.3129 REMARK 3 18 1.7900 - 1.7500 0.49 1418 82 0.2571 0.3044 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.182 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.874 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4888 REMARK 3 ANGLE : 1.296 6727 REMARK 3 CHIRALITY : 0.053 722 REMARK 3 PLANARITY : 0.010 837 REMARK 3 DIHEDRAL : 15.654 672 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8FDL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1000270455. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAY-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-002 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48508 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 49.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 200 DATA REDUNDANCY : 1.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 1.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3P5Q REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3.6 M AMMONIUM PHOSPHATE/SULFATE, PH REMARK 280 7.4, BATCH MODE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.34150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -217.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL B 1 REMARK 465 HIS B 2 REMARK 465 VAL D 1 REMARK 465 HIS D 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU D 22 O HOH D 301 1.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU D 22 CD GLU D 22 OE2 -0.072 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU D 22 OE1 - CD - OE2 ANGL. DEV. = -11.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS B 77 42.18 -142.13 REMARK 500 HIS B 77 43.55 -142.13 REMARK 500 HIS C 45 65.51 -119.32 REMARK 500 ASP C 75 51.94 -154.39 REMARK 500 LYS C 90 -66.45 -122.82 REMARK 500 ASN D 80 48.94 -154.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 87 NE2 REMARK 620 2 HEM A 201 NA 96.8 REMARK 620 3 HEM A 201 NB 97.5 87.6 REMARK 620 4 HEM A 201 NC 104.4 158.6 86.7 REMARK 620 5 HEM A 201 ND 107.3 86.9 155.1 89.6 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 92 NE2 REMARK 620 2 HEM B 201 NA 95.2 REMARK 620 3 HEM B 201 NB 100.6 88.7 REMARK 620 4 HEM B 201 NC 100.9 163.7 90.6 REMARK 620 5 HEM B 201 ND 98.9 88.6 160.5 86.6 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM C 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 87 NE2 REMARK 620 2 HEM C 201 NA 97.8 REMARK 620 3 HEM C 201 NB 97.0 87.9 REMARK 620 4 HEM C 201 NC 106.0 156.2 88.0 REMARK 620 5 HEM C 201 ND 108.7 88.3 154.3 85.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM D 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 92 NE2 REMARK 620 2 HEM D 201 NA 95.1 REMARK 620 3 HEM D 201 NB 100.5 89.7 REMARK 620 4 HEM D 201 NC 103.8 161.0 88.7 REMARK 620 5 HEM D 201 ND 99.5 86.6 159.9 88.4 REMARK 620 N 1 2 3 4 DBREF 8FDL A 1 141 UNP P69905 HBA_HUMAN 2 142 DBREF 8FDL B 1 146 UNP P68871 HBB_HUMAN 2 147 DBREF 8FDL C 1 141 UNP P69905 HBA_HUMAN 2 142 DBREF 8FDL D 1 146 UNP P68871 HBB_HUMAN 2 147 SEQRES 1 A 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 A 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 A 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 A 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 A 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 A 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 A 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 A 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 A 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 A 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 A 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 146 VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 B 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 B 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 B 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 B 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 B 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 B 146 HIS CSD ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 B 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 B 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 B 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 B 146 LYS TYR HIS SEQRES 1 C 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 C 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 C 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 C 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 C 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 C 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 C 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 C 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 C 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 C 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 C 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 D 146 VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 D 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 D 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 D 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 D 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 D 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 D 146 HIS CSD ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 D 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 D 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 D 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 D 146 LYS TYR HIS MODRES 8FDL CSD B 93 CYS MODIFIED RESIDUE MODRES 8FDL CSD D 93 CYS MODIFIED RESIDUE HET CSD B 93 13 HET CSD D 93 13 HET HEM A 201 73 HET SO4 A 202 5 HET SO4 A 203 5 HET HEM B 201 73 HET GOL B 202 14 HET SO4 B 203 5 HET SO4 B 204 5 HET SO4 B 205 5 HET HEM C 201 73 HET GOL C 202 14 HET GOL C 203 14 HET GOL C 204 14 HET XQU C 205 33 HET SO4 C 206 5 HET SO4 C 207 5 HET SO4 C 208 5 HET HEM D 201 73 HETNAM CSD 3-SULFINOALANINE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM XQU NITROSOCHLORAMPHENICOL HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE HETSYN HEM HEME HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN XQU 2,2-DICHLORO-N-{(1R,2R)-1,3-DIHYDROXY-1-[4- HETSYN 2 XQU (HYDROXYAMINO)PHENYL]PROPAN-2-YL}ACETAMIDE FORMUL 2 CSD 2(C3 H7 N O4 S) FORMUL 5 HEM 4(C34 H32 FE N4 O4) FORMUL 6 SO4 8(O4 S 2-) FORMUL 9 GOL 4(C3 H8 O3) FORMUL 17 XQU C11 H14 CL2 N2 O4 FORMUL 22 HOH *568(H2 O) HELIX 1 AA1 SER A 3 GLY A 18 1 16 HELIX 2 AA2 HIS A 20 PHE A 36 1 17 HELIX 3 AA3 PRO A 37 PHE A 43 5 7 HELIX 4 AA4 SER A 52 HIS A 72 1 21 HELIX 5 AA5 ASP A 75 LEU A 80 1 6 HELIX 6 AA6 LEU A 80 LYS A 90 1 11 HELIX 7 AA7 PRO A 95 ALA A 111 1 17 HELIX 8 AA8 THR A 118 SER A 138 1 21 HELIX 9 AA9 THR B 4 GLY B 16 1 13 HELIX 10 AB1 ASN B 19 TYR B 35 1 17 HELIX 11 AB2 PRO B 36 PHE B 42 5 7 HELIX 12 AB3 THR B 50 ASN B 57 1 8 HELIX 13 AB4 ASN B 57 LEU B 75 1 19 HELIX 14 AB5 ALA B 76 ASP B 79 5 4 HELIX 15 AB6 ASN B 80 LYS B 95 1 16 HELIX 16 AB7 PRO B 100 GLY B 119 1 20 HELIX 17 AB8 LYS B 120 PHE B 122 5 3 HELIX 18 AB9 THR B 123 HIS B 143 1 21 HELIX 19 AC1 SER C 3 GLY C 18 1 16 HELIX 20 AC2 HIS C 20 PHE C 36 1 17 HELIX 21 AC3 PRO C 37 PHE C 43 5 7 HELIX 22 AC4 SER C 52 HIS C 72 1 21 HELIX 23 AC5 ASP C 75 LEU C 80 1 6 HELIX 24 AC6 LEU C 80 LYS C 90 1 11 HELIX 25 AC7 PRO C 95 LEU C 113 1 19 HELIX 26 AC8 THR C 118 SER C 138 1 21 HELIX 27 AC9 THR D 4 GLY D 16 1 13 HELIX 28 AD1 ASN D 19 TYR D 35 1 17 HELIX 29 AD2 PRO D 36 GLY D 46 5 11 HELIX 30 AD3 THR D 50 ASN D 57 1 8 HELIX 31 AD4 ASN D 57 LEU D 75 1 19 HELIX 32 AD5 ALA D 76 LEU D 78 5 3 HELIX 33 AD6 ASN D 80 LYS D 95 1 16 HELIX 34 AD7 PRO D 100 GLY D 119 1 20 HELIX 35 AD8 LYS D 120 PHE D 122 5 3 HELIX 36 AD9 THR D 123 HIS D 143 1 21 LINK C HIS B 92 N CSD B 93 1555 1555 1.32 LINK C CSD B 93 N ASP B 94 1555 1555 1.32 LINK C HIS D 92 N CSD D 93 1555 1555 1.33 LINK C CSD D 93 N ASP D 94 1555 1555 1.32 LINK NE2 HIS A 87 FE HEM A 201 1555 1555 2.17 LINK NE2 HIS B 92 FE HEM B 201 1555 1555 2.16 LINK NE2 HIS C 87 FE HEM C 201 1555 1555 2.23 LINK NE2 HIS D 92 FE HEM D 201 1555 1555 2.18 CRYST1 53.551 82.683 62.586 90.00 100.02 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018674 0.000000 0.003299 0.00000 SCALE2 0.000000 0.012094 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016226 0.00000